Related references
Note: Only part of the references are listed.Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
Yuying Liu et al.
SCIENCE IMMUNOLOGY (2020)
Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice
Yushu Joy Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial)
C. R. Mehta et al.
ANNALS OF ONCOLOGY (2019)
Nanobody Based Dual Specific CARs
Stijn De Munter et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Natural Single-Domain Antibody-Nanobody: A Novel Concept in the Antibody Field
Cui Li et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2018)
Reprogramming human T cell function and specificity with non-viral genome targeting
Theodore L. Roth et al.
NATURE (2018)
Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease
Matthew J. Johnson et al.
SCIENTIFIC REPORTS (2018)
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2 thorn Breast Cancer Metastasis to the Brain
Saul J. Priceman et al.
CLINICAL CANCER RESEARCH (2018)
Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery
Pieterjan Debie et al.
MOLECULAR PHARMACEUTICS (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the safe harbor AAVS1 locus
Julio Castano et al.
STEM CELL RESEARCH (2017)
Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer
Nathan Singh et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2017)
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
Hamid R. Mirzaei et al.
FRONTIERS IN IMMUNOLOGY (2017)
Phase I and Preliminary Phase II Study ofTRC105in Combination with Sorafenib in Hepatocellular Carcinoma
Austin G. Duffy et al.
CLINICAL CANCER RESEARCH (2017)
Circulating tumor cells and CDX models as a tool for preclinical drug development
Alice Lallo et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2017)
A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma
Andrea B. Apolo et al.
CLINICAL GENITOURINARY CANCER (2017)
Specific determination of influenza H7N2 virus based on biotinylated single-domain antibody from a phage-displayed library
Xue Gong et al.
ANALYTICAL BIOCHEMISTRY (2016)
CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia
Nathan Singh et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Smart CARs engineered for cancer immunotherapy
Saul J. Priceman et al.
CURRENT OPINION IN ONCOLOGY (2015)
Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells
Van Trung Chu et al.
NATURE BIOTECHNOLOGY (2015)
Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44+CD62Lhigh IL-7R+ CTLs with up- and downregulation of anti- and pro-apoptosis genes
Rong Wang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Development of nanobody-based flow injection chemiluminescence immunoassay for sensitive detection of human prealbumin
Lei Ma et al.
BIOSENSORS & BIOELECTRONICS (2014)
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
Marcela V. Maus et al.
BLOOD (2014)
Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1
Min Zhu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer
Yingmiao Liu et al.
CANCER MEDICINE (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Nanobodies and their potential applications
Gholamreza Hassanzadeh-Ghassabeh et al.
NANOMEDICINE (2013)
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain et al.
CANCER DISCOVERY (2013)
Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
Melody A. Swartz et al.
CANCER RESEARCH (2012)
A combined strategy improves the solubility of aggregation-prone single-chain variable fragment antibodies
Wei Sun et al.
PROTEIN EXPRESSION AND PURIFICATION (2012)
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
Chrystal U. Louis et al.
BLOOD (2011)
De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks
Magdy M. Mahfouz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
Ketao Jin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome
Russell C. DeKelver et al.
GENOME RESEARCH (2010)
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Josiane E. Garneau et al.
NATURE (2010)
General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
Cecile Vincke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Properties, production, and applications of camelid single-domain antibody fragments
M. M. Harmsen et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2007)
Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen
E Dolk et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Monoclonal versus polyclonal antibodies: Distinguishing characteristics, applications, and information resources
NS Lipman et al.
ILAR JOURNAL (2005)
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels
E Fonsatti et al.
ONCOGENE (2003)
Share Paper
